Loading…

AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma

BACKGROUND: This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 2011-05, Vol.117 (10), p.2170-2177
Main Authors: Farges, Olivier, Fuks, David, Le Treut, Yves‐Patrice, Azoulay, Daniel, Laurent, Alexis, Bachellier, Philippe, Nuzzo, Gennaro, Belghiti, Jacques, Pruvot, François René, Regimbeau, Jean Marc
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2382-490dc37dccbdb154912f478a96103b37d55b7d646bc53f6cf4324fe0882558103
cites
container_end_page 2177
container_issue 10
container_start_page 2170
container_title Cancer
container_volume 117
creator Farges, Olivier
Fuks, David
Le Treut, Yves‐Patrice
Azoulay, Daniel
Laurent, Alexis
Bachellier, Philippe
Nuzzo, Gennaro
Belghiti, Jacques
Pruvot, François René
Regimbeau, Jean Marc
description BACKGROUND: This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been validated, was tested in the current study. METHODS: Among 522 patients operated on with curative intent for an IHCC between 1994 and 2008 in tertiary hepatobiliary centers, those with mass‐forming‐type IHCCs, an R0 resection, and accurate pathological node staging were retained for evaluation. The distribution of these patients and their actuarial survival in the new TNM stages (as well as in the 4 previous ones) were compared. RESULTS: Only 163 patients fulfilled the inclusion criteria, mainly because of the lack of routine lymphadenectomy, but patients and tumors characteristics of this population were representative. These patients were evenly distributed between AJCC 7th edition stages (stage I, 28%; stage II, 32%; stage III, 35%), which was not the case for the other systems. With an average follow‐up of 34 months in survivors, the AJCC 7th edition was more discriminating than the others in predicting survival (median for stage I not reached; for stage II, 53 months, P = .01; for stage III, 16 months, P < .0001). Survival of these patients according to the 2 Japanese classifications was identical to that anticipated. CONCLUSIONS: The 7th edition is clinically relevant and may be applicable worldwide, provided routine lymphadenectomy at the time of surgery for IHCC becomes the standard of care. Cancer 2011. © 2010 American Cancer Society. This year the AJCC has implemented a new staging system for intrahepatic cholangiocarcinoma that has not been validated yet. The present study shows that it is more discriminative than the 2 Western and the 2 Eastern classifications previously used.
doi_str_mv 10.1002/cncr.25712
format article
fullrecord <record><control><sourceid>wiley</sourceid><recordid>TN_cdi_wiley_primary_10_1002_cncr_25712_CNCR25712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CNCR25712</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2382-490dc37dccbdb154912f478a96103b37d55b7d646bc53f6cf4324fe0882558103</originalsourceid><addsrcrecordid>eNotkF1LwzAYhYMoOKc3_oL8gc58Nu3lKH5M5gSZ4F1J3yZbpEtHkjF24X-3nV6953AOB94HoXtKZpQQ9gAewoxJRdkFmlBSqoxQwS7RhBBSZFLwr2t0E-P3YBWTfIJ-5q9VhVXaYtO65HqPe4vXqzcck944v8Ea4BB0Mt0Jty5CcDvnBxtxf0jQ70Zh8V4nZ3yK-OiGpWCigaSbzmDnU9BbM-aAYdt32m9cDzqA8_1O36Irq7to7v7vFH0-Pa6rl2z5_ryo5ssMGC9YJkrSAlctQNM2VIqSMitUocucEt4MgZSNanORNyC5zcEKzoQ1pCiYlMXQmSL6t3t0nTnV--ELHU41JfVIrR6p1WdqdbWqPs6K_wJZcGS3</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>EZB Electronic Journals Library</source><creator>Farges, Olivier ; Fuks, David ; Le Treut, Yves‐Patrice ; Azoulay, Daniel ; Laurent, Alexis ; Bachellier, Philippe ; Nuzzo, Gennaro ; Belghiti, Jacques ; Pruvot, François René ; Regimbeau, Jean Marc</creator><creatorcontrib>Farges, Olivier ; Fuks, David ; Le Treut, Yves‐Patrice ; Azoulay, Daniel ; Laurent, Alexis ; Bachellier, Philippe ; Nuzzo, Gennaro ; Belghiti, Jacques ; Pruvot, François René ; Regimbeau, Jean Marc</creatorcontrib><description>BACKGROUND: This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been validated, was tested in the current study. METHODS: Among 522 patients operated on with curative intent for an IHCC between 1994 and 2008 in tertiary hepatobiliary centers, those with mass‐forming‐type IHCCs, an R0 resection, and accurate pathological node staging were retained for evaluation. The distribution of these patients and their actuarial survival in the new TNM stages (as well as in the 4 previous ones) were compared. RESULTS: Only 163 patients fulfilled the inclusion criteria, mainly because of the lack of routine lymphadenectomy, but patients and tumors characteristics of this population were representative. These patients were evenly distributed between AJCC 7th edition stages (stage I, 28%; stage II, 32%; stage III, 35%), which was not the case for the other systems. With an average follow‐up of 34 months in survivors, the AJCC 7th edition was more discriminating than the others in predicting survival (median for stage I not reached; for stage II, 53 months, P = .01; for stage III, 16 months, P &lt; .0001). Survival of these patients according to the 2 Japanese classifications was identical to that anticipated. CONCLUSIONS: The 7th edition is clinically relevant and may be applicable worldwide, provided routine lymphadenectomy at the time of surgery for IHCC becomes the standard of care. Cancer 2011. © 2010 American Cancer Society. This year the AJCC has implemented a new staging system for intrahepatic cholangiocarcinoma that has not been validated yet. The present study shows that it is more discriminative than the 2 Western and the 2 Eastern classifications previously used.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.25712</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>biliary tumor ; cholangiocarcinoma ; primary liver tumor ; staging ; surgery</subject><ispartof>Cancer, 2011-05, Vol.117 (10), p.2170-2177</ispartof><rights>Copyright © 2010 American Cancer Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2382-490dc37dccbdb154912f478a96103b37d55b7d646bc53f6cf4324fe0882558103</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Farges, Olivier</creatorcontrib><creatorcontrib>Fuks, David</creatorcontrib><creatorcontrib>Le Treut, Yves‐Patrice</creatorcontrib><creatorcontrib>Azoulay, Daniel</creatorcontrib><creatorcontrib>Laurent, Alexis</creatorcontrib><creatorcontrib>Bachellier, Philippe</creatorcontrib><creatorcontrib>Nuzzo, Gennaro</creatorcontrib><creatorcontrib>Belghiti, Jacques</creatorcontrib><creatorcontrib>Pruvot, François René</creatorcontrib><creatorcontrib>Regimbeau, Jean Marc</creatorcontrib><title>AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma</title><title>Cancer</title><description>BACKGROUND: This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been validated, was tested in the current study. METHODS: Among 522 patients operated on with curative intent for an IHCC between 1994 and 2008 in tertiary hepatobiliary centers, those with mass‐forming‐type IHCCs, an R0 resection, and accurate pathological node staging were retained for evaluation. The distribution of these patients and their actuarial survival in the new TNM stages (as well as in the 4 previous ones) were compared. RESULTS: Only 163 patients fulfilled the inclusion criteria, mainly because of the lack of routine lymphadenectomy, but patients and tumors characteristics of this population were representative. These patients were evenly distributed between AJCC 7th edition stages (stage I, 28%; stage II, 32%; stage III, 35%), which was not the case for the other systems. With an average follow‐up of 34 months in survivors, the AJCC 7th edition was more discriminating than the others in predicting survival (median for stage I not reached; for stage II, 53 months, P = .01; for stage III, 16 months, P &lt; .0001). Survival of these patients according to the 2 Japanese classifications was identical to that anticipated. CONCLUSIONS: The 7th edition is clinically relevant and may be applicable worldwide, provided routine lymphadenectomy at the time of surgery for IHCC becomes the standard of care. Cancer 2011. © 2010 American Cancer Society. This year the AJCC has implemented a new staging system for intrahepatic cholangiocarcinoma that has not been validated yet. The present study shows that it is more discriminative than the 2 Western and the 2 Eastern classifications previously used.</description><subject>biliary tumor</subject><subject>cholangiocarcinoma</subject><subject>primary liver tumor</subject><subject>staging</subject><subject>surgery</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNotkF1LwzAYhYMoOKc3_oL8gc58Nu3lKH5M5gSZ4F1J3yZbpEtHkjF24X-3nV6953AOB94HoXtKZpQQ9gAewoxJRdkFmlBSqoxQwS7RhBBSZFLwr2t0E-P3YBWTfIJ-5q9VhVXaYtO65HqPe4vXqzcck944v8Ea4BB0Mt0Jty5CcDvnBxtxf0jQ70Zh8V4nZ3yK-OiGpWCigaSbzmDnU9BbM-aAYdt32m9cDzqA8_1O36Irq7to7v7vFH0-Pa6rl2z5_ryo5ssMGC9YJkrSAlctQNM2VIqSMitUocucEt4MgZSNanORNyC5zcEKzoQ1pCiYlMXQmSL6t3t0nTnV--ELHU41JfVIrR6p1WdqdbWqPs6K_wJZcGS3</recordid><startdate>20110515</startdate><enddate>20110515</enddate><creator>Farges, Olivier</creator><creator>Fuks, David</creator><creator>Le Treut, Yves‐Patrice</creator><creator>Azoulay, Daniel</creator><creator>Laurent, Alexis</creator><creator>Bachellier, Philippe</creator><creator>Nuzzo, Gennaro</creator><creator>Belghiti, Jacques</creator><creator>Pruvot, François René</creator><creator>Regimbeau, Jean Marc</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope/></search><sort><creationdate>20110515</creationdate><title>AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma</title><author>Farges, Olivier ; Fuks, David ; Le Treut, Yves‐Patrice ; Azoulay, Daniel ; Laurent, Alexis ; Bachellier, Philippe ; Nuzzo, Gennaro ; Belghiti, Jacques ; Pruvot, François René ; Regimbeau, Jean Marc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2382-490dc37dccbdb154912f478a96103b37d55b7d646bc53f6cf4324fe0882558103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>biliary tumor</topic><topic>cholangiocarcinoma</topic><topic>primary liver tumor</topic><topic>staging</topic><topic>surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Farges, Olivier</creatorcontrib><creatorcontrib>Fuks, David</creatorcontrib><creatorcontrib>Le Treut, Yves‐Patrice</creatorcontrib><creatorcontrib>Azoulay, Daniel</creatorcontrib><creatorcontrib>Laurent, Alexis</creatorcontrib><creatorcontrib>Bachellier, Philippe</creatorcontrib><creatorcontrib>Nuzzo, Gennaro</creatorcontrib><creatorcontrib>Belghiti, Jacques</creatorcontrib><creatorcontrib>Pruvot, François René</creatorcontrib><creatorcontrib>Regimbeau, Jean Marc</creatorcontrib><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Farges, Olivier</au><au>Fuks, David</au><au>Le Treut, Yves‐Patrice</au><au>Azoulay, Daniel</au><au>Laurent, Alexis</au><au>Bachellier, Philippe</au><au>Nuzzo, Gennaro</au><au>Belghiti, Jacques</au><au>Pruvot, François René</au><au>Regimbeau, Jean Marc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma</atitle><jtitle>Cancer</jtitle><date>2011-05-15</date><risdate>2011</risdate><volume>117</volume><issue>10</issue><spage>2170</spage><epage>2177</epage><pages>2170-2177</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>BACKGROUND: This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been validated, was tested in the current study. METHODS: Among 522 patients operated on with curative intent for an IHCC between 1994 and 2008 in tertiary hepatobiliary centers, those with mass‐forming‐type IHCCs, an R0 resection, and accurate pathological node staging were retained for evaluation. The distribution of these patients and their actuarial survival in the new TNM stages (as well as in the 4 previous ones) were compared. RESULTS: Only 163 patients fulfilled the inclusion criteria, mainly because of the lack of routine lymphadenectomy, but patients and tumors characteristics of this population were representative. These patients were evenly distributed between AJCC 7th edition stages (stage I, 28%; stage II, 32%; stage III, 35%), which was not the case for the other systems. With an average follow‐up of 34 months in survivors, the AJCC 7th edition was more discriminating than the others in predicting survival (median for stage I not reached; for stage II, 53 months, P = .01; for stage III, 16 months, P &lt; .0001). Survival of these patients according to the 2 Japanese classifications was identical to that anticipated. CONCLUSIONS: The 7th edition is clinically relevant and may be applicable worldwide, provided routine lymphadenectomy at the time of surgery for IHCC becomes the standard of care. Cancer 2011. © 2010 American Cancer Society. This year the AJCC has implemented a new staging system for intrahepatic cholangiocarcinoma that has not been validated yet. The present study shows that it is more discriminative than the 2 Western and the 2 Eastern classifications previously used.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/cncr.25712</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 2011-05, Vol.117 (10), p.2170-2177
issn 0008-543X
1097-0142
language eng
recordid cdi_wiley_primary_10_1002_cncr_25712_CNCR25712
source Wiley-Blackwell Read & Publish Collection; EZB Electronic Journals Library
subjects biliary tumor
cholangiocarcinoma
primary liver tumor
staging
surgery
title AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A33%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AJCC%207th%20edition%20of%20TNM%20staging%20accurately%20discriminates%20outcomes%20of%20patients%20with%20resectable%20intrahepatic%20cholangiocarcinoma&rft.jtitle=Cancer&rft.au=Farges,%20Olivier&rft.date=2011-05-15&rft.volume=117&rft.issue=10&rft.spage=2170&rft.epage=2177&rft.pages=2170-2177&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.25712&rft_dat=%3Cwiley%3ECNCR25712%3C/wiley%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2382-490dc37dccbdb154912f478a96103b37d55b7d646bc53f6cf4324fe0882558103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true